Location History:
- Yokohama, JP (2017)
- Kanagawa, JP (2016 - 2021)
Company Filing History:
Years Active: 2016-2024
Title: Naoyuki Okamoto: Innovator in Pancreatic Cancer Evaluation
Introduction
Naoyuki Okamoto is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of medical technology, particularly in the evaluation of pancreatic cancer. With a total of 6 patents to his name, Okamoto's work is at the forefront of innovation in cancer diagnostics.
Latest Patents
Okamoto's latest patents include a range of inventions aimed at improving the evaluation of pancreatic cancer. These patents are:
1. Method for evaluating pancreatic cancer
2. Pancreatic cancer evaluating apparatus
3. Pancreatic cancer evaluating method
4. Pancreatic cancer evaluating program product
5. Pancreatic cancer evaluating system
6. Information communication terminal apparatus
One of his notable inventions is a method for evaluating pancreatic cancer, which involves obtaining amino acid concentration data from blood samples. This method evaluates the state of pancreatic cancer by calculating a value using the obtained data and a previously established formula. The formula incorporates concentration values of various amino acids, allowing for a comprehensive assessment of the patient's condition.
Another significant invention is a workpiece placement platform device designed for precise positioning of plate-shaped workpieces. This device features a positioning member that can move in and out relative to the platform's surface, enabling efficient and accurate workpiece placement.
Career Highlights
Throughout his career, Naoyuki Okamoto has worked with notable companies such as Ajinomoto Co., Ltd. and Amada Holdings Company Ltd. His experience in these organizations has contributed to his expertise in developing innovative solutions for complex problems in the medical field.
Collaborations
Okamoto has collaborated with esteemed colleagues, including Akira Imaizumi and Toshihiko Ando. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in technology.
Conclusion
Naoyuki Okamoto's contributions to the field of pancreatic cancer evaluation demonstrate his commitment to innovation and improving patient outcomes. His patents reflect a deep understanding of medical technology and a dedication to advancing cancer diagnostics.